Minoxidil topique 2 % face à Minoxidil topique 0,01 %

Table III. Change from baseline target area hair Change from base- line target area hair Placebo 0.01% counts (N = 18) (N -- lS) Vellus (_SD) 9 (-+89) 37 (---59) Range - 154~. 195 -55, 164 Nonvellus (-+SD) 81 (---95) 48 (+57) Range -37,251 -52, 162 Total (__SD) 90 (___89) 84 (+-69) Range -40, 286 -21, 161 SD: Standard deviation.

Citation complémentaire (methode)

thus conservative. Univariate analyses were inspected for differences between dose levels with the use of Duncan's multiple range test at a significance level of 0.05. In addition, X2 tests were used to evaluate dif-

Citation complémentaire (significativite)

sis, the changes in (log) total and (log) nonvellus hair counts were significantly associated with treat- ment group (p = 0.04 and 0.02, respectively; Table III). The change from baseline vellus hair counts were not significantly associated with treat- ment group (p = 0.43). Duncan's multiple range test indicated that, for (log) total hair counts, the 2% minoxidil treatment group results were signif- icantly greater than the 0.01% and 0.1% topical minoxidil and placebo groups. The nonvellus (log) count was also significantly greater for the 2% topical minoxidil group than for the 0.01% topical minoxidil and placebo groups. There was no sta- tistically significant difference between the 2% and 1% topical minoxidil groups in terms of mean change in nonvellus or total hair counts from base- line to the end of this study.

Citation complémentaire (valeur)

counts relative to treatment group Treatment group Topical minoxidil 2% 0.1% I 1% (N = 15) (N = 15) (N = 17) 11 (±87) -31 (+_92) -15 (+_ 121) - 184, 123 -245, 58 -342, 176 81 (_+68) 180 (_+ 126) 190 (___ 136) -32, 267 27, 395 38, 551 92 (-+79) 149 (+93) 175 (+99) -30, 209 15,362 38, 347

Olsen EA, DeLong ER, Weiner MS. Dose-response study of topical minoxidil in male pattern baldness.. J Am Acad Dermatol 1986, DOI 10.1016/s0190-9622(86)70138-2. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

Table III. Change from baseline target area hair Change from base- line target area hair Placebo 0.01% counts (N = 18) (N -- lS) Vellus (_SD) 9 (-+89) 37 (---59) Range - 154~. 195 -55, 164 Nonvellus (-+SD) 81 (---95) 48 (+57) Range -37,251 -52, 162 Total (__SD) 90 (___89) 84 (+-69) Range -40, 286 -21, 161 SD: Standard deviation.

Citation complémentaire (methode)

thus conservative. Univariate analyses were inspected for differences between dose levels with the use of Duncan's multiple range test at a significance level of 0.05. In addition, X2 tests were used to evaluate dif-

Citation complémentaire (significativite)

sis, the changes in (log) total and (log) nonvellus hair counts were significantly associated with treat- ment group (p = 0.04 and 0.02, respectively; Table III). The change from baseline vellus hair counts were not significantly associated with treat- ment group (p = 0.43). Duncan's multiple range test indicated that, for (log) total hair counts, the 2% minoxidil treatment group results were signif- icantly greater than the 0.01% and 0.1% topical minoxidil and placebo groups. The nonvellus (log) count was also significantly greater for the 2% topical minoxidil group than for the 0.01% topical minoxidil and placebo groups. There was no sta- tistically significant difference between the 2% and 1% topical minoxidil groups in terms of mean change in nonvellus or total hair counts from base- line to the end of this study.

Olsen EA, DeLong ER, Weiner MS. Dose-response study of topical minoxidil in male pattern baldness.. J Am Acad Dermatol 1986, DOI 10.1016/s0190-9622(86)70138-2. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

Table III. Change from baseline target area hair Change from base- line target area hair Placebo 0.01% counts (N = 18) (N -- lS) Vellus (_SD) 9 (-+89) 37 (---59) Range - 154~. 195 -55, 164 Nonvellus (-+SD) 81 (---95) 48 (+57) Range -37,251 -52, 162 Total (__SD) 90 (___89) 84 (+-69) Range -40, 286 -21, 161 SD: Standard deviation.

Citation complémentaire (methode)

thus conservative. Univariate analyses were inspected for differences between dose levels with the use of Duncan's multiple range test at a significance level of 0.05. In addition, X2 tests were used to evaluate dif-

Citation complémentaire (significativite)

sis, the changes in (log) total and (log) nonvellus hair counts were significantly associated with treat- ment group (p = 0.04 and 0.02, respectively; Table III). The change from baseline vellus hair counts were not significantly associated with treat- ment group (p = 0.43). Duncan's multiple range test indicated that, for (log) total hair counts, the 2% minoxidil treatment group results were signif- icantly greater than the 0.01% and 0.1% topical minoxidil and placebo groups. The nonvellus (log) count was also significantly greater for the 2% topical minoxidil group than for the 0.01% topical minoxidil and placebo groups. There was no sta- tistically significant difference between the 2% and 1% topical minoxidil groups in terms of mean change in nonvellus or total hair counts from base- line to the end of this study.

Citation complémentaire (valeur)

counts relative to treatment group Treatment group Topical minoxidil 2% 0.1% I 1% (N = 15) (N = 15) (N = 17) 11 (±87) -31 (+_92) -15 (+_ 121) - 184, 123 -245, 58 -342, 176 81 (_+68) 180 (_+ 126) 190 (___ 136) -32, 267 27, 395 38, 551 92 (-+79) 149 (+93) 175 (+99) -30, 209 15,362 38, 347

Olsen EA, DeLong ER, Weiner MS. Dose-response study of topical minoxidil in male pattern baldness.. J Am Acad Dermatol 1986, DOI 10.1016/s0190-9622(86)70138-2. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

Table III. Change from baseline target area hair Change from base- line target area hair Placebo 0.01% counts (N = 18) (N -- lS) Vellus (_SD) 9 (-+89) 37 (---59) Range - 154~. 195 -55, 164 Nonvellus (-+SD) 81 (---95) 48 (+57) Range -37,251 -52, 162 Total (__SD) 90 (___89) 84 (+-69) Range -40, 286 -21, 161 SD: Standard deviation.

Olsen EA, DeLong ER, Weiner MS. Dose-response study of topical minoxidil in male pattern baldness.. J Am Acad Dermatol 1986, DOI 10.1016/s0190-9622(86)70138-2. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).